The Nooner, by 24/7 Market News for July 6, 2022

(24/7 MARKET NEWS) There’s a bunch of listings that are shaping up for a potential afternoon run. Of course, that doesn’t guarantee that any of them will, but

ThermoGenesis Holdings Inc. (NASDAQ:THMO) just had a sudden volume spike and is trading at $0.415, up $0.184 (+79.65%), on more than 27 million shares. The volume and price spike happened within the last hour and, assuming the volume remains, it could challenger today’s high and spike higher.

[mstock id=”73007″ asset=”thmo”]

Trevi Therapeutics, Inc. (NASDAQ:TRVI) announced Positive Results last week when we mentioned that it was at $2.28 and it had a compelling chart. At $3.45, up $0.11 (+3.29%), on over 750 thousand shares, its chart is even more compelling, as it could reach a new 52 week high.

[mstock id=”73007″ asset=”trvi”]

About the same time, we stated that Decibel Therapeutics (NASDAQ:DBTX) shares were “poised to gain as they report top line data from Phase 1 trial”, when it was in the mid-$2 range. It’s now $4.90, 60 cents higher on the day (+13.95%), after hitting $5, on nearly 400 thousand shares. If it can break through the next inflection point, around $5.20, it looks like it wants to challenge the low $7 range.

[mstock id=”73007″ asset=”DBTX”]

Eos Energy Enterprises (NASDAQ:EOSE) shares are at $1.52, up $0.26 (+20.63%), over 41 million shares traded, on news of continued orders and existing backlog.

[mstock id=”73007″ asset=”EOSE”]

Scworx (NASDAQ:WORX) shares shot up this morning on its share buyback program news. It’s at $0.865, up $0.245 (+39.52%), on over 27 million shares.

[mstock id=”73007″ asset=”WORX”]

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) is at $2.22, 97 cents higher (+77.61%), on over 72 million shares traded. It’s not a great nooner chart, but, if this morning’s big volume returns, it may make another run at today’s $2.65 high.

[mstock id=”73007″ asset=”IINN”]

Kalera PLC (NASDAQ:KAL) ran hard this morning and has been consolidating, so it may make another run. It’s currently at $4.09, up $1.29 (+46.07%), on nearly 3.5 million shares.

[mstock id=”73007″ asset=”KAL”]

First Wave BioPharma (NASDAQ:FWBI) is at $0.26, up $0.052 (+25.00%), on nearly 4 million shares traded. The late volume and price spike could lead to further gains today.

[mstock id=”73007″ asset=”FWBI”]

Humanigen Inc. (NASDAQ:HGEN) is at $2.15, up $0.34 (+18.51%) on over 4 million shares.

[mstock id=”73007″ asset=”HGEN”]

Omega Therapeutics is at $4.92, 86 cents higher (+21.18%) on over 280 thousand shares. It has a nice one-day chart, but needs volume.

Cano Health Inc. (NYSE:CANO) is at $5.60, 79 cents higher (+16.42%), on more than 12 million shares traded.

[mstock id=”73007″ asset=”CANO”]

Scholar Rock (NASDAQ:SRRK) is at $6.85, up $0.97 (+16.50%) on over 1.2 million shares.

[mstock id=”73007″ asset=”SRRK”]

If Evofem Biosciences (NASDAQ:EVFM) can break through its recent $1.50 high, it looks like it could challenge the low $2 range. It’s at $1.2697, up $0.1697, (+15.43%) on over 73 million shares.

[mstock id=”73007″ asset=”EVFM”]
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.